Investigators: Liechti ME, Gamma A, Vollenweider, FX Sponsors/Funding: Swiss National Science Foundation; Swiss Federal Health Office; Heffter Research Institute References: Psychopharmacology DOI (2001) …
Investigator: Marcus Lumby, PhD candidate Sponsorship: includes small grant from MAPS Anthropological investigation, first phase completed. Field Reports MAPS article
Investigators: Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH Abraham Ribicoff Center Clinical Neuroscience Research Unit of theConnecticut Mental Health Center, New Haven …
(doctoral dissertation) Investigator: Roger Marsden California Institute of Integral Studies, Clinical Psychology Contact: Sponsors: 1998 Kranzke Scholarship; MAPS What are the different frameworks being …
Investigator: Rick Doblin, Ph.D. This study, originally published in the Journal of Psychoactive Drugs [Oct-Dec 1998] is one in a series of long-term follow-ups to early psychedelic research that MAPS …
Investigator: David Abrahart Contact: This study will demonstrate the contemporary relevance of a re-evaluation of research concerning LSD and its effects on mental health. It outlines the objectives and …
Investigators: Dafters RI, Duffy F, O’Donnell P, Bouquet C Psychology Department, Glasgow University, Glasgow, Scotland G12 8RT Sponsor(s)/Funding: Self funded Contact: N/A References: Psychopharmacology …
Announcement of the Department of Health and Human Services’ Guidance on Procedures for the Provision of Marijuana for Medical Research.
Investigators: Rick Doblin, Jerry Beck, PhD, Kate Chapman, Maureen Alioto Los Angeles Area, California Contact Sponsor: MAPS The following report constitutes a forty-year+ follow-up interview study of …
Investigator: Rudolf Brenneisen, PhD University of Bern, Switzerland Contact: br> Completed and published, just a few subjects. Also see the details and references section.
Investigator: Manfred Spitzer, MD, PhD et al. Psychiatrische Universitats Klinic, Heidelberg, Germany Human clinical study, completed and published. More psilocybin research in Germany Spitzer M, et al. …
Investigator: Rick Strassman, MD University of New Mexico, USA Psychobiological study. Phase 1 dose-response study Sponsor: NIDA Begun, not completed due to personal reasons unrelated to study itself. …
